Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
about
Cost of clinical events in health economic evaluations in Germany: a systematic review.Building the Case for Clopidogrel as a World Health Organization Essential Medicine.Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerationsCost-effectiveness of clopidogrel: seeing through the smoke.Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for Greece.
P2860
Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cost-effectiveness of clopidog ...... the CLARITY and COMMIT trials.
@en
type
label
Cost-effectiveness of clopidog ...... the CLARITY and COMMIT trials.
@en
prefLabel
Cost-effectiveness of clopidog ...... the CLARITY and COMMIT trials.
@en
P2093
P1476
Cost-effectiveness of clopidog ...... the CLARITY and COMMIT trials.
@en
P2093
Bengt Jönsson
David Parry
Jenny Berg
Julie Spiesser
P304
P356
10.1016/J.CLINTHERA.2007.06.020
P577
2007-06-01T00:00:00Z